chr16-70289223-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBA1

The NM_001605.3(AARS1):​c.-22+198G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 151,838 control chromosomes in the GnomAD database, including 13,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.42 ( 13687 hom., cov: 30)

Consequence

AARS1
NM_001605.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.427

Publications

19 publications found
Variant links:
Genes affected
AARS1 (HGNC:20): (alanyl-tRNA synthetase 1) The human alanyl-tRNA synthetase (AARS) belongs to a family of tRNA synthases, of the class II enzymes. Class II tRNA synthases evolved early in evolution and are highly conserved. This is reflected by the fact that 498 of the 968-residue polypeptide human AARS shares 41% identity witht the E.coli protein. tRNA synthases are the enzymes that interpret the RNA code and attach specific aminoacids to the tRNAs that contain the cognate trinucleotide anticodons. They consist of a catalytic domain which interacts with the amino acid acceptor-T psi C helix of the tRNA, and a second domain which interacts with the rest of the tRNA structure. [provided by RefSeq, Jul 2008]
AARS1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease axonal type 2N
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • developmental and epileptic encephalopathy, 29
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • trichothiodystrophy 8, nonphotosensitive
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 16-70289223-C-T is Benign according to our data. Variant chr16-70289223-C-T is described in ClinVar as Benign. ClinVar VariationId is 1248821.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.425 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AARS1NM_001605.3 linkc.-22+198G>A intron_variant Intron 1 of 20 ENST00000261772.13 NP_001596.2
AARS1XM_047433666.1 linkc.-22+198G>A intron_variant Intron 1 of 15 XP_047289622.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AARS1ENST00000261772.13 linkc.-22+198G>A intron_variant Intron 1 of 20 1 NM_001605.3 ENSP00000261772.8

Frequencies

GnomAD3 genomes
AF:
0.423
AC:
64220
AN:
151720
Hom.:
13675
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.415
Gnomad AMI
AF:
0.514
Gnomad AMR
AF:
0.386
Gnomad ASJ
AF:
0.460
Gnomad EAS
AF:
0.419
Gnomad SAS
AF:
0.272
Gnomad FIN
AF:
0.525
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.429
Gnomad OTH
AF:
0.427
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.423
AC:
64270
AN:
151838
Hom.:
13687
Cov.:
30
AF XY:
0.425
AC XY:
31515
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.415
AC:
17177
AN:
41394
American (AMR)
AF:
0.386
AC:
5884
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.460
AC:
1595
AN:
3468
East Asian (EAS)
AF:
0.419
AC:
2141
AN:
5114
South Asian (SAS)
AF:
0.271
AC:
1305
AN:
4814
European-Finnish (FIN)
AF:
0.525
AC:
5540
AN:
10562
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.429
AC:
29149
AN:
67914
Other (OTH)
AF:
0.426
AC:
900
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1883
3766
5648
7531
9414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
600
1200
1800
2400
3000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.425
Hom.:
5706
Bravo
AF:
0.417

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
8.2
DANN
Benign
0.79
PhyloP100
-0.43
PromoterAI
-0.025
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34087264; hg19: chr16-70323126; API